FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 74 filers reported holding FATE THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $334,875 | -95.3% | 102,096 | -89.4% | 0.00% | -100.0% |
| Q1 2024 | $7,086,263 | +1363.6% | 965,431 | +645.8% | 0.00% | – |
| Q4 2023 | $484,158 | +81.8% | 129,454 | +3.1% | 0.00% | – |
| Q3 2023 | $266,245 | -52.9% | 125,587 | +5.7% | 0.00% | – |
| Q2 2023 | $565,469 | -19.5% | 118,796 | -3.6% | 0.00% | – |
| Q1 2023 | $702,588 | +46.7% | 123,261 | +159.6% | 0.00% | – |
| Q4 2022 | $479,063 | -58.2% | 47,479 | -7.2% | 0.00% | – |
| Q3 2022 | $1,146,000 | -2.8% | 51,166 | +7.6% | 0.00% | – |
| Q2 2022 | $1,179,000 | -97.0% | 47,550 | -95.3% | 0.00% | -100.0% |
| Q1 2022 | $39,356,000 | -23.8% | 1,015,117 | +14.9% | 0.01% | -16.7% |
| Q4 2021 | $51,680,000 | +623.9% | 883,279 | +633.3% | 0.01% | +500.0% |
| Q3 2021 | $7,139,000 | -90.7% | 120,447 | -86.4% | 0.00% | -89.5% |
| Q2 2021 | $76,734,000 | +37.4% | 884,134 | +30.6% | 0.02% | +26.7% |
| Q1 2021 | $55,831,000 | +44.9% | 677,136 | +59.8% | 0.02% | +36.4% |
| Q4 2020 | $38,541,000 | +199.9% | 423,856 | +31.8% | 0.01% | +175.0% |
| Q3 2020 | $12,853,000 | +1412.1% | 321,547 | +1197.9% | 0.00% | – |
| Q2 2020 | $850,000 | -74.0% | 24,774 | -83.2% | 0.00% | -100.0% |
| Q1 2020 | $3,275,000 | +222.0% | 147,462 | +194.3% | 0.00% | – |
| Q2 2019 | $1,017,000 | +8.9% | 50,107 | -5.8% | 0.00% | – |
| Q1 2019 | $934,000 | +2.8% | 53,179 | -25.0% | 0.00% | – |
| Q4 2018 | $909,000 | -90.5% | 70,862 | -87.9% | 0.00% | -100.0% |
| Q3 2018 | $9,559,000 | +362.5% | 586,778 | +222.0% | 0.00% | +200.0% |
| Q2 2018 | $2,067,000 | +2985.1% | 182,236 | +778.8% | 0.00% | – |
| Q2 2017 | $67,000 | +17.5% | 20,736 | +66.4% | 0.00% | – |
| Q1 2017 | $57,000 | – | 12,465 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $11,083,330 | 2.77% |
| Redmile Group, LLC | 13,169,057 | $43,194,507 | 2.61% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 497,360 | $1,631,341 | 2.06% |
| Boxer Capital, LLC | 8,215,910 | $26,948,185 | 1.42% |
| Deep Track Capital, LP | 5,572,607 | $18,278,151 | 0.55% |
| Vestal Point Capital, LP | 2,000,000 | $6,560,000 | 0.49% |
| Bruce & Co., Inc. | 300,000 | $984,000 | 0.32% |
| Octagon Capital Advisors LP | 520,800 | $1,708,224 | 0.27% |
| Integral Health Asset Management, LLC | 850,000 | $2,788,000 | 0.26% |
| Bellevue Group AG | 4,839,779 | $15,874,475 | 0.26% |